144 related articles for article (PubMed ID: 9544385)
21. Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.
Ungerer M; Faßbender J; Li Z; Münch G; Holthoff HP
Clin Rev Allergy Immunol; 2017 Apr; 52(2):182-193. PubMed ID: 27368808
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
23. [Immunopathology of Graves'-Basedow disease].
Baj Z; Ferenc T; Lewiński A
Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
[TBL] [Abstract][Full Text] [Related]
24. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of pathophysiology of Graves' disease by animal models].
Akamizu T
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):329-35. PubMed ID: 14752933
[No Abstract] [Full Text] [Related]
26. Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves' and Hashimoto's diseases.
Inoue N; Watanabe M; Katsumata Y; Hidaka Y; Iwatani Y
Tissue Antigens; 2013 Oct; 82(4):288-90. PubMed ID: 23962080
[No Abstract] [Full Text] [Related]
27. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
29. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
30. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
31. The role of genetics in Graves' disease and thyroid orbitopathy.
Kim N; Hatton MP
Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
[TBL] [Abstract][Full Text] [Related]
32. Genetics of thyroid autoimmunity and the role of the TSHR.
Brand OJ; Gough SC
Mol Cell Endocrinol; 2010 Jun; 322(1-2):135-43. PubMed ID: 20083159
[TBL] [Abstract][Full Text] [Related]
33. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens.
Balazs C; Bokk A; Molnar I; Stenszky V; Farid NR
Exp Clin Immunogenet; 1989; 6(2):190-2. PubMed ID: 2629892
[No Abstract] [Full Text] [Related]
34. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
35. Graves' animal models of Graves' hyperthyroidism.
Nagayama Y
Thyroid; 2007 Oct; 17(10):981-8. PubMed ID: 17822377
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
Hoang TD; Mai VQ; Clyde PW; Shakir MK
Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
[TBL] [Abstract][Full Text] [Related]
37. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
[No Abstract] [Full Text] [Related]
38. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
39. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves' ophthalmopathy.
Major BJ; Cures A; Frauman AG
Biochem Biophys Res Commun; 1997 Jan; 230(3):493-6. PubMed ID: 9015347
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of Graves' ophthalmopathy--current understanding.
Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2001 Feb; 86(2):501-3. PubMed ID: 11157999
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
